Andrew Lin

7PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 09, 2024
Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation.

Mary Nauffal, Stephen Eng, Andrew Lin

|Oct 31, 2023
Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide-based transplant.

Andrew Lin, Samantha Brown, Stephanie Chinapen

|Jun 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.

Roni Tamari, Michael Scordo, Binni M Kunvarjee

|Jul 08, 2022
Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults.

Ioannis Politikos, Carmen Lau, Sean M Devlin

|Feb 10, 2022
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation.

Andrew Lin, Samantha Brown, Molly Maloy

|Oct 05, 2019
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.

Andrew Lin, Molly Maloy, Yiqi Su

Pageof 2

Frequent Collaborators

4 joint publications

Miguel-Angel Perales

4 joint publications

Sergio Giralt

2 joint publications

Boglarka Gyurkocza

2 joint publications

Brian Shaffer